Koji Teramoto

J-GLOBAL         Last updated: Oct 28, 2019 at 17:47
 
Avatar
Name
Koji Teramoto
Affiliation
Shiga University of Medical Science
Section
Undergraduate School of Medicine
Job title
Assistant Professor
Degree
M.D., Ph.D.(Shiga University of Medical Science)

Research Areas

 
 

Education

 
 
 - 
2005
Graduate School, Division of Medical Sciences, Shiga University of Medical Science
 
 
 - 
1996
Faculty of Medicine, Shiga University of Medical Science
 

Awards & Honors

 
2008
2008 AACR-Afrac, Inc. Scholar-in-Training Award
 
Apr 2008
AACR-Afrac Scholar-in-Training Award, Association for Cancer Research (AACR)
 

Published Papers

 
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka, Mitsuaki Ishida, Jun Hanaoka, Hidetoshi Sumimoto, Yataro Daigo
137 56-63   Nov 2019   [Refereed]
Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer
Yoko Kataoka, Yasuhiko Ohshio, Koji Teramoto, Tomoyuki Igarashi, Tohru Asai, Jun Hanaoka
Oncology Reports   41(2) 853-862   Feb 2019   [Refereed]
Blocking the FSTL1-DIP2A axis improves anti-tumor immunity
Chie Kudo-Saito, Akiko Ishida, Yuji Shouya, Koji Teramoto, Tomoyuki Igarashi, Ryoko Kon, Kenji Saito, Chihiro Awada, Yamato Ogiwara, Masayoshi Toyoura
Cell Reports   24(7) 1790-1801   Aug 2018   [Refereed]
The mechanism of de novo expression of programmed cell death-ligand 1 in squamous cell carcinoma of the lung
Tomoyuki Igarashi*, Koji Teramoto*, Mitsuaki Ishida, Jun Hanaoka, Yataro Daigo (*equally contributed)
Oncology Reports   38(4) 2189-2196   2017   [Refereed]
Quantitative analysis and clonal characterization of T-cell receptor β repertoires in patients with advanced non-small cell lung cancer treated with cancer vaccine
Tu Mai, Atsushi Takano, Hiroyuki Suzuki, Takashi Hirose, Takahiro Mori, Koji Teramoto, Kazuma Kiyotani, Yusuke Nakamura, Yataro Daigo
Oncology Letters   14(1) 283-292   2017   [Refereed]
Clinical outcome of posterior fixation surgery in patients with vertebral metastasis of lung cancer
Tomoyuki Igarashi, Keigo Okamoto, Koji Teramoto*, Ryosuke Kaku, Keiko Ishida, Keiko Ueda, Yo Kawaguchi, Masayuki Hashimoto, Shoji Kitamura, Noriaki Tezuka, Jun Hanaoka (*corresponding author)
Molecular and Clinical Oncology   6(5) 770-774   2017   [Refereed]
Predictive biomarkers and effectineness of MUC1-targeted dendritic cell-based vaccine in patients with refractory non-small-cell lung cancer.
Koji Teramoto, Yoshitomo Ozaki, Jun Hanaoka, Satoru Sawai, Noriaki Tezuka, Shozo Fujino, Yataro Daigo, Keiichi Kontani.
Therapeutic Advances in Medical Oncology   9(3) 147-157   2017   [Refereed]
Ryosuke Kaku, Koji Teramoto*, Keiko Ishida, Tomoyuki Igarashi, Masayuki Hashimoto, Shoji Kitamura, Noriaki Tezuka, Tohru Asai, Jun Hanaoka. (*corresponding author)
Asian Journal of Surgery   40(2) 123-128   2017   [Refereed]
Scoring PD-L1 expression intensity on pulmonary adenocarcimonas and the correlations with clinicopathological factors.
Tomoyuki Igarashi, Koji Teramoto, Mitsuaki Ishida, Jun Hanaoka, Yataro Daigo.
ESMO Open   1(4) e000083   2016   [Refereed]
Induction of metronomic chemotherapy for metastatic breast cancer: Clinical outcomes and responsive subtypes.
Keiichi Kontani, Shin-ichiro Hashimoto, Chisa Murazawa, Shoko Norimura, Hiroaki Tanaka, Masahiro Ohtani, Naomi Fujiwara-Honjo, Manabu Date, Koji Teramoto, Hitoshi Houchi, Hiroyasu Yokomise.
Molecular and Clinical Oncology   4(6) 947-953   2016   [Refereed]
Hidetoshi Sumimoto, Atsushi Takano, Koji Teramoto, Yataro Daigo
PLos One   11(11) e0166626   2016   [Refereed]
Yasuhiko Ohshio, Koji Teramoto*, Jun Hanaoka, Noriaki Tezuka, Yasushi Itoh, Tohru Asai, Yataro Daigo, Kazumasa Ogasawara. (*corresponding author)
Cancer Science   106(2) 134-142   2015   [Refereed]
Keiichi Kontani, Shin-ichiro Hashimoto, Chisa Murazawa, Shoko Norimura, Hiroaki Tanaka, Masahiro Ohtani, Naomi Fujiwara-Honjo, Manabu Date, Koji Teramoto, Hitoshi Houchi, Hiroyasu Yokomise.
World Journal of Surgical Oncology   12(1) 344   2014   [Refereed]
Yasuhiko Ohshio, Jun Hanaoka, Keiichi Kontani, Koji Teramoto*. (*corresponding author)
Scandinavian Journal of Immunology   80(6) 408-416   2014   [Refereed]
Yataro Daigo, Atsushi Takano, Koji Teramoto, Suyoun Chung, Yusuke Nakamura.
Clinical Pharmacology and Therapeutics   94(2) 218-223   2013   [Refereed]
Yasuhiko Ohshio, Koji Teramoto*, Masayuki Hashimoto, Shoji Kitamura, Jun Hanaoka, Keiichi Kontani. (*corresponding author)
Oncology Reports   30(2) 1000-1006   2013   [Refereed]
Koji Teramoto, Yasuhiko Ohshio, Takuya Fujita, Jun Hanaoka, Keiichi Kontani
ournal of Cancer Research and Clinical Oncology   139(5) 861-870   2013   [Refereed]
Koji Teramoto, Yo Kawaguchi, Tetsuo Hori, Mitsuaki Ishida, Masayuki Hashimoto, Shoji Kitamura, Makoto Motoishi, Jun Hanaoka, Noriaki Tezuka, Hidetoshi Okabe.
Surgery Today   42(10) 988-991   2012   [Refereed]
Koji Teramoto, Yoshikuni Asada, Yoshitomo Ozaki, Yuji Suzumura, Yasutaka Nakano, Satoru Sawai, Noriaki Tezuka, Shuhei Inoue, Fujino, Shozo
Cancer Chemotherapy and Pharmacology   70(4) 531-537   2012   [Refereed]
A pulmonary infarction mimicking metastatic lung cancer
Koji Teramoto, You Kawaguchi, Tetsuo Hori, Yasuhiko Ohshio, Masayuki Hashimoto, Shoji Kitamura, Jun Hanaoka, Noriaki Tezuka.
Surgical Science   2(6) 360-362   2011   [Refereed]
Tokuhiro Chano, Kaichiro Ikebuchi, Yasuhiko Tomita, Yufen Jin, Hideo Inaji, Makoto Ishitobi, Koji Teramoto, Yasuko Ochi, Hitosuke Tameno, Ichiro Nishimura, Kahori Minami, Hirokazu Inoue, Takahiro Isono, Masao Saitoh, Taketoshi Shimada, Yasuo Hisa, Hidetoshi Okabe.
PLoS One   5(12) e15737   2010   [Refereed]
Takuya Fujita, Koji Teramoto*, Yoshitomo Ozaki, Jun Hanaoka, Noriaki Tezuka, Yasushi Itoh, Tohru Asai, Shozo Fujino, Keiichi Kontani, Kazumasa Ogasawara. (*corresponding author)
Cancer Research   69(12) 5142-5150   2009   [Refereed]
Koji Teramoto, Yuji Suzumura.
General Thoracic and Cardiovascular Surgery   56(2) 88-90   2008   [Refereed]
Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Keiichi Kontani, Koji Teramoto, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Hideaki Ishida, Kiichi Kajino, Shozo Fujino, Akira Yamauchi, Osamu Taguchi, Reiji Kannagi, Hiroyasu Yokomise, Kazumasa Ogasawara.
Oncology Reports   17(4) 895-902   2007   [Refereed]
Koji Teramoto, Yuji Suzumura.
Surgery Today   37(12) 1087-1089   2007   [Refereed]
Koji Teramoto, Keiichi Kontani, Takuya Fujita, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Shozo Fujino, Yasushi Itoh, Osamu Taguchi, Reiji Kannagi, Kazumasa Ogasawara.
Cancer Immunology,Immunotherapy   56(3) 331-342   2007   [Refereed]
Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi, Hitosuke Tameno, Yasuhiko Tomita, Yufen Jin, Hideo Inaji, Makoto Ishitobi, Koji Teramoto, Ichiro Nishimura, Kahori Minami, Hirokazu Inoue, Takahiro Isono, Masao Saitoh, Taketoshi Shimada, Yasuo Hisa, Hidetoshi Okabe.
PLoS One   5(6) e11404   2006   [Refereed]
Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
Keiichi Kontani, Koji Teramoto, Yoshitomo Ozaki, Takuya Fujita, Noriaki Tezuka, Satoru Sawai, Hiroyoshi Watanabe, Shozo Fujino, Hiroyasu Yokomise, Iwao Ohkubo.
International Journal of Oncology   25(6) 1537-1542   2004   [Refereed]
Involvement of 90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer.
Yoshitomo Ozaki, Keiichi Kontani, Koji Teramoto, Takuya Fujita, Noriaki Tezuka, Satoru Sawai, T Maeda, Hiroyoshi Watanabe, Shozo Fujino, Tohru Asai, Iwao Ohkubo.
Oncology Reports   12(5) 1071-1077   2004   [Refereed]
Yoshitomo Ozaki, Keiichi Kontani, Koji Teramoto, Takuya Fujita, Noriaki Tezuka, Satoru Sawai, Hiroyoshi Watanabe, Shozo Fujino, Tohru Asai, Iwao Ohkubo.
Biochemical and Biophysical Research Communications   317(4) 1089-1095   2004   [Refereed]
Expression of RB1CC1, a novel tumor suppressor gene, is inversely correlated with the Ki-67 proliferation index in primary breast cancers
Koji Teramoto, Tokuhiro Chano, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Keiichi Kontani, Shozo Fujino, Hidetoshi Okabe.
Cancer Therapy   1 103-107   2003   [Refereed]
Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy
Koji Teramoto, Keiichi Kontani, Yoshitomo Ozaki, Satoru Sawai, Noriaki Tezuka, Toshi Nagata, Shozo Fujino, Yasushi Itoh, Osamu Taguchi, Yukio Koide, Tohru Asai, Iwao Ohkubo, Kazumasa Ogasawara.
Cancer Research   63 7920-7925   2003   [Refereed]
Yoshitomo Ozaki, Keiichi Kontani, Hanaoka Jun, Tokuhiro Chano, Koji Teramoto, Noriaki Tezuka, Satoru Sawai, Shozo Fujino, T Yoshiki, Hidetoshi Okabe, Iwao Ohkubo.
Cancer   95(9) 1954-1962   2002   [Refereed]
Tokuhiro Chano, Keiichi Kontani, Koji Teramoto, Hidetoshi Okabe, Shiro Ikegawa.
Nature Genetics   31(3) 285-288   2002   [Refereed]
Koji Teramoto, Masayoshi Kuwabara, Yoshito Matsubara.
Respiration   69(3) 280-282   2002   [Refereed]
Koji Teramoto, Naoki Yamashita, Masayoshi Kuwabara, Takeshi Hanawa, Teruo Matsui, Yoshito Matsubara.
Surgery Today   31(9) 820-822   2001   [Refereed]